Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.

Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecotière L, Bridoux F, Mandart L, Hanrotel-Saliou C, Stanescu C, Depraetre P, Gie S, Massad M, Kersalé A, Séret G, Augusto JF, Saliou P, Maestri S, Chen JM, Harris PC, Férec C, Le Meur Y.

Am J Kidney Dis. 2017 Oct;70(4):476-485. doi: 10.1053/j.ajkd.2017.01.046. Epub 2017 Mar 27.

2.

Corrigendum to "Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism" [Diabetes Metab. 41 (2015) 331-337].

de Kerdanet M, Caron-Debarle M, Nivot S, Gaillot T, Lascols O, Fremont B, Bonnaure-Mallet M, Gie S, Massart C, Capeau J.

Diabetes Metab. 2016 Dec;42(6):e1. doi: 10.1016/j.diabet.2016.10.001. Epub 2016 Nov 16. No abstract available.

PMID:
27865655
3.

Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism.

de Kerdanet M, Caron-Debarle M, Nivot S, Gaillot T, Lascols O, Fremont B, Bonnaure-Mallet M, Gie S, Massart C, Capeau J.

Diabetes Metab. 2015 Sep;41(4):331-7. doi: 10.1016/j.diabet.2014.11.001. Epub 2014 Nov 25. Erratum in: Diabetes Metab. 2016 Dec;42(6):e1. Bonaure, M [corrected to Bonnaure-Mallet , M].

PMID:
25465274
4.

C3 nephritic factor associated with C3 glomerulopathy in children.

Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.

Pediatr Nephrol. 2014 Jan;29(1):85-94. doi: 10.1007/s00467-013-2605-6. Epub 2013 Sep 26.

PMID:
24068526
5.

[Effects of exercise training on ergocycle during hemodialysis in patients with end stage renal disease: relevance of the anaerobic threshold intensity].

Besnier F, Laruelle E, Genestier S, Gié S, Vigneau C, Carré F.

Nephrol Ther. 2012 Jul;8(4):231-7. doi: 10.1016/j.nephro.2011.10.002. Epub 2011 Nov 18. French.

PMID:
22100992
6.

Mutations of NPHP2 and NPHP3 in infantile nephronophthisis.

Tory K, Rousset-Rouvière C, Gubler MC, Morinière V, Pawtowski A, Becker C, Guyot C, Gié S, Frishberg Y, Nivet H, Deschênes G, Cochat P, Gagnadoux MF, Saunier S, Antignac C, Salomon R.

Kidney Int. 2009 Apr;75(8):839-47. doi: 10.1038/ki.2008.662. Epub 2009 Jan 28.

7.

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.

Frémeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP.

Blood. 2008 Dec 15;112(13):4948-52. doi: 10.1182/blood-2008-01-133702. Epub 2008 Sep 16.

8.

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C; French Society of Pediatric Nephrology.

J Am Soc Nephrol. 2007 Aug;18(8):2392-400. Epub 2007 Jun 28.

9.

Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.

Taque S, Peudenier S, Gie S, Rambeau M, Gandemer V, Bridoux L, Bétrémieux P, De Parscau L, Le Gall E.

Pediatr Nephrol. 2004 Mar;19(3):276-80. Epub 2004 Feb 3.

PMID:
14758527
10.

[Natural history of vascular ports for hemodialysis after renal transplantation].

Bensalah K, Guillé F, Rivalan J, Joyeux V, Gié S, Laruelle E, Garry J, Morin MP, Le Pogamp P, Lobel B, Patard JJ.

Prog Urol. 2001 Apr;11(2):231-4. French.

PMID:
11400483
11.

[Glomerular nephropathy with IgA mesangium deposits and Crohn disease].

Dabadie A, Gié S, Taque S, Babut JM, Roussey M.

Arch Pediatr. 1996 Sep;3(9):884-7. French.

PMID:
8949351
12.

[Neurotoxicity of acyclovir in peritoneal dialysis apropos of 1 case].

Guilhem I, Charasse C, Gary J, Gie S, Rivalan J, Le Pogamp P, Beneton C, Lokiec F.

Nephrologie. 1991;12(5):241-3. French.

PMID:
1766532
13.

Nephrotic syndrome in a child with cystic fibrosis.

Roussey M, Dabadie A, Lennon A, Gie S, Legall E, Le Marec B.

Acta Paediatr Scand. 1988 Nov;77(6):920-1. No abstract available.

PMID:
3207027
14.

[Prognosis and treatment of glomerulonephritis of periarteritis nodosa. The role of plasma exchange].

Jarrousse B, Guillevin L, Gie S, Bletry O, Barrier J, Cassuto-Viguier E, Ang KS, Besancenot JF, Sobel A.

Ann Med Interne (Paris). 1988;139 Suppl 1:23-5. French.

PMID:
2907849
15.

[Hemolytic-uremic syndrome in children. Experiences at the CHR of Rennes].

Oriot D, Le Gall E, Gie S, Lefrançois C, Roussey M, Thomas R, Ramee MP.

Ann Pediatr (Paris). 1987 Jun;34(6):423-7. French. No abstract available.

PMID:
3619311
16.

[Unusual metabolic alkalosis in chronic renal failure].

Thoreux PH, Chevet D, Le Pogamp P, Gie S, Rivalan J.

Ann Med Interne (Paris). 1986;137(7):601-2. French. No abstract available.

PMID:
3813304
17.

Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.

Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.

Ann Gastroenterol Hepatol (Paris). 1984 Jan-Feb;20(1):1-6. English, French.

PMID:
6529154
18.

[A new case of hepatitis due to glafenine].

Brissot P, Gie S, Colobert A, Delamaire D, Cartier F, Bourel M.

Gastroenterol Clin Biol. 1982 Nov;6(11):948. French. No abstract available.

PMID:
6130026
19.

[Pseudotetanus caused by prochlorperazine (Stemetil)].

Gie SH.

Maandschr Kindergeneeskd. 1968 Aug;36(4):132-5. Dutch. No abstract available.

PMID:
5676532

Supplemental Content

Support Center